Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $147.9300 (0.93%) ($146.5900 - $151.8600) on Wed. Dec. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.22% (three month average) | RSI | 52 | Latest Price | $147.9300(0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.61% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) DIA(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.61% (StdDev 3.22%) | Hourly BBV | 0 () | Intraday Trend | -0% | | | |
|
Resistance Level | $152.75 | 5 Day Moving Average | $148.46(-0.36%) | 10 Day Moving Average | $153.84(-3.84%) | 20 Day Moving Average | $152.75(-3.16%) | To recent high | -46.1% | To recent low | 1.6% | Market Cap | $2.377b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |